Blocking two cancer pathways may curb medulloblastoma relapse, preclinical study suggests
For most children diagnosed with medulloblastoma, the most common malignant pediatric brain tumor, survival rates are encouraging. But for a subset, remission is not the end of the story. Roughly 30% of patients will see ...
May 26, 2026
0
8









